SIRT1 and lung carcinoma: Based on the above findings that SIRT1 ISGylation promotes cell proliferation and suppresses apoptosis, it is reasonable to postulate that SIRT1 ISGylation plays an important role in lung cancer progression and sensitivity to DNA damage-based therapeutics.